|
× |
 |
FERRIC OXIDE YELLOW Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
|
× |
 |
SODIUM ALGINATE Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
|
× |
 |
COPOVIDONE Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
|
× |
 |
FD&C GREEN NO. 3 Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
|
× |
 |
EPIDIOLEX (cannabidiol) Drug Profile, 2024 |
$699.00 |
|
$699.00 |
|
× |
 |
CETOSTEARYL ALCOHOL Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
|
× |
 |
D&C YELLOW NO. 10 Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
|
× |
 |
DIETHYLENE GLYCOL MONOETHYL ETHER Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
|
× |
 |
EXONDYS 51 (eteplirsen) Drug Profile, 2024 |
$699.00 |
|
$699.00 |
|
|